<i>N</i>-Acetylaspartylglutamate (NAAG) Pretreatment Reduces Hypoxic-Ischemic Brain Damage and Oxidative Stress in Neonatal Rats
<i>N</i>-acetylaspartylglutamate (NAAG), the most abundant peptide transmitter in the mammalian nervous system, activates mGluR3 at presynaptic sites, inhibiting the release of glutamate, and acts on mGluR3 on astrocytes, stimulating the release of neuroprotective growth factors (TGF-β)....
Saved in:
Main Authors: | Ewelina Bratek (Author), Apolonia Ziembowicz (Author), Elzbieta Salinska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracerebroventricular administration of <it>N</it>-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain
by: Kozikowski Alan, et al.
Published: (2008) -
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model
by: Vicini Stefano, et al.
Published: (2010) -
The Mechanism of the Neuroprotective Effect of Kynurenic Acid in the Experimental Model of Neonatal Hypoxia-Ischemia: The Link to Oxidative Stress
by: Ewelina Bratek-Gerej, et al.
Published: (2021) -
Gallic acid inhibits neuroinflammation and reduces neonatal hypoxic-ischemic brain damages
by: Xiangjun Dong, et al.
Published: (2022) -
Pretreatment with Human Chorionic Gonadotropin Protects the Neonatal Brain against the Effects of Hypoxic-Ischemic Injury
by: Tammy Z. Movsas, et al.
Published: (2017)